FDA

44 statements across 19 episodes · 27 bullish · 11 bearish · 10 people on the record · first statement Mar 15, 2020 by David Friedberg · across every show →

Everything said about FDA, oldest first

Mar 15, 2020 positive
Opinion
Friedberg: Remdesivir should be widely distributed in hospitals without compassionate use restrictions
“Rendesivir should be broadly and widely available right now. People shouldn't have to file for compassionate use to get it. They should be making it, printing it should be in every hospital, and people can decide whether or not they want to take the risk.”
David Friedberg Mar 15, 2020 ▶ 52:02 E0: COVID-19 Political, Economic & Social Ramifications featuring David Friedberg
Apr 11, 2020 negative
Opinion
Sacks: Public health agency responses amount to malpractice and negligence
“But if by health system, we mean the FDA, the CDC the WHO, which is part of the U S system, but we do rely on them to some extent. You've just seen, I think, you know, amazing really malpractice or negligence. If they were a pharma company, I think they'd be s…”
David Sacks Apr 11, 2020 ▶ 13:04 E2: Rebooting economy, understanding corporate debt, avoiding a depression & more with David Sacks
Apr 11, 2020 positive
Opinion
Sacks: FDA was right to issue emergency trial authorization for hydroxychloroquine
“And so, you know, I think the FDA did the right thing giving emergency trial authorization to doctors to be able to try this with their patients.”
David Sacks Apr 11, 2020 ▶ 25:49 E2: Rebooting economy, understanding corporate debt, avoiding a depression & more with David Sacks
Jun 13, 2021
Assertion Contradicted
Chamath: Every prior Alzheimer's drug submitted to the FDA failed
“Every single Alzheimer's drug that's ever gone through the FDA has been rejected and has failed.”
Chamath Palihapitiya Jun 13, 2021 ▶ 9:14 E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
Jun 13, 2021 positive
Opinion
Sacks: FDA should conditionally approve terminal disease drugs as Phase 4 trials
“These people have nothing to lose, and so I would let the drug through, I think, and then watch how it performs over the next couple of years. They could always revoke the approval in two years, you know. In other words, almost consider the usage of the drug o…”
David Sacks Jun 13, 2021 ▶ 17:53 E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
Jan 6, 2023 bullish
Assertion Supported
Friedberg: 27 FDA-approved cell/gene therapies exist with 1,000+ in clinical trials
“There are currently 27 FDA-approved cell and gene therapies on the market. There are over a thousand in clinical trials, many of which are already showing extraordinary efficacy and benefit.”
David Friedberg Jan 6, 2023 ▶ 1:20:14 E110: 2023 Bestie Predictions!
Mar 31, 2023 bullish
Disclosure
Chamath: Portfolio company has fully closed-loop AI cancer detection system under FDA review
“There are closed loop systems. We have one right now that's in front of the FDA. That is a total closed loop system that will not need any human input.”
Chamath Palihapitiya Mar 31, 2023 ▶ 1:11:21 E122: Is AI the next great computing platform? ChatGPT vs. Google, containing AGI & RESTRICT Act
Apr 14, 2023 bearish
Prediction Not checkable as stated
Sacks: FDA-style AI regulation will destroy US innovation and empower foreign rivals
“And what we will do by racing to create a new FDA is destroying American innovation in the sector, and other countries will not slow down. They will beat us to the punch here.”
David Sacks Apr 14, 2023 ▶ 1:01:32 E124: AutoGPT's massive potential and risk, AI regulation, Bob Lee/SF update
Jul 21, 2023 negative
Insight
Ramaswamy: FDA regulation crowds out individual consumer scrutiny of medicines
“I think people would be far more. Scrutinizing of the medicines they took if it didn't come with the crowding out effect of that individual level of self-responsibility and due diligence that the government wasn't doing.”
Vivek Ramaswamy Jul 21, 2023 ▶ 53:44 In conversation with Vivek Ramaswamy
Sep 16, 2023 negative
Assertion Supported
Gurley: FDA antigen test chief previously worked at Quidel and Abbott
“Now, he works for the FDA, and he runs the group that oversees which antigen test gets approved. I know this because he would write scathing letters to the ones he rejected that you can also look up online. Now, guess what? You're not going to be surprised. Fi…”
Bill Gurley Sep 16, 2023 ▶ 16:59 All-In Summit: Bill Gurley presents 2,851 Miles
Sep 25, 2023
Assertion Contradicted
FDA blocks clinical trials for lifestyle gene therapies like aging or sleep
“The FDA only lets you queue up clinical trials to test drugs that are for diseases, but aging is not a disease state. Wanting to sleep fewer hours is not a disease state. Insomnia is, but wanting to just sleep fewer hours and be fully rested is not a disease s…”
Dr. Nicole Paulk Sep 25, 2023 ▶ 20:23 All-In Summit: Gene therapy and a new era of medicine with Dr. Nicole Paulk
Oct 8, 2024 positive
Assertion Not checkable as stated
Eli Lilly reduced its drug development timeline from 11 to 6.1 years
“We've moved the drug development timeline, which the industry is about nine years, from first human dose to FDA approval. And when I started, ours was about 11. And now we're 6.1.”
Dave Ricks Oct 8, 2024 ▶ 58:41 Dave Ricks, CEO of Eli Lilly | The All-In Interview
Oct 8, 2024 positive
Assertion Not checkable as stated
Ricks: Eli Lilly cut FDA submission prep time to under two weeks
“We have a submission document to get in and it used to be our standard was a 120 days from when you had the data to when you send it to the FDA. We're now doing that routinely inside of two weeks.”
Dave Ricks Oct 8, 2024 ▶ 59:25 Dave Ricks, CEO of Eli Lilly | The All-In Interview
Jan 19, 2025 neutral
Assertion Contradicted
Cruz: 'Results Act' would mandate FDA reciprocity with other developed nations
“The Results Act says that if any pharmaceutical, any medical device is approved in another major developed country, so approved in Canada or Japan or the EU, That the FDA has 60 days to approve it here, or it's deemed automatically approved by operation.”
Senator Ted Cruz Jan 19, 2025 ▶ 46:39 Ted Cruz: Trump's First Week, Texas vs. California, Immigration, DOGE, Greenland
Jan 20, 2025 neutral
Prediction Held up
Friedberg: Microplastics problem will trigger FDA and EPA regulatory reviews
“So the microplastic problem is something that will certainly trigger A bunch of FDA review, a bunch of EPA review.”
David Friedberg Jan 20, 2025 ▶ 1:49:40 All-In Inauguration Day Livestream with the Besties from Washington, DC!
Jan 15, 2026 positive
Prediction Partly held up
Makary predicts GLP-1 drug starter pricing will drop to $149
“With the GLP-I example, for example, it's gonna come down to a 149 dollars for the first three months.”
Dr. Marty Makary Jan 15, 2026 ▶ 1:00:41 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Assertion Supported
FDA to allow Bayesian statistics in clinical trial evaluations
“Which we announced this week. We are now going to allow Bayesian statistics to be used.”
Dr. Marty Makary Jan 15, 2026 ▶ 20:25 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Assertion Supported
FDA issues 1,500 drug ad enforcement letters under Makary
“I sent out 1500 enforcement letters, including over a hundred cease and desist letters for ads that were creating a misleading impression, including online pharmacies that are advertising drugs without the same, ah side effects that pharma companies list when …”
Dr. Marty Makary Jan 15, 2026 ▶ 1:10:42 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 negative
Assertion Supported
Makary: U.S. food supply contains over 1,000 chemicals banned elsewhere
“So we have basically said we have a thousand chemicals plus in the U.S. Food supply that do, are not allowed in other food system supplies.”
Dr. Marty Makary Jan 15, 2026 ▶ 1:17:24 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Assertion Supported
FDA eliminates select regulatory requirements for cell and gene therapies
“And we announced just this week that we are getting rid of the, some of the regulatory requirements for cell and gene therapy.”
Dr. Marty Makary Jan 15, 2026 ▶ 26:44 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Disclosure
Makary: FDA granted 18 vouchers for rapid-approval pilot program
“We have, I think, 18 products that have vouchers for this new pilot program.”
Dr. Marty Makary Jan 15, 2026 ▶ 17:20 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Disclosure
Makary: Federal health officials released reduced core vaccine schedule of 38 doses
“So we gave them a list that constitutes about 38 doses from age zero to 18.”
Dr. Marty Makary Jan 15, 2026 ▶ 52:52 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Disclosure
Makary: FDA reduces default drug approval requirement to one pivotal trial
“We announced just last month that we are going to go from a baseline default requirement of two pivotal trials for a drug to one pivotal trial for a drug.”
Dr. Marty Makary Jan 15, 2026 ▶ 14:13 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Assertion Supported
Makary: FDA now makes all drug rejection letters public
“Our rejection letter is public, so that if the FDA does not approve a drug, the public deserves to know why.”
Dr. Marty Makary Jan 15, 2026 ▶ 5:08 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Assertion Not checkable as stated
Makary says he has approved 100% of Right to Try requests
“And I have signed 100% of Right to Try requests that come across my desk.”
Dr. Marty Makary Jan 15, 2026 ▶ 25:57 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Assertion Contradicted
FDA Commissioner Makary announces 42 major reforms in first 10 months
“We have announced 42 major reforms in my 10 months in office at the FDA.”
Dr. Marty Makary Jan 15, 2026 ▶ 4:36 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Assertion Supported
Makary: FDA created a plausible mechanism pathway for bespoke gene therapies
“These bespoke therapies, we created essentially a novel pathway for them. Dr. Vinay Prasad described it in the New England Journal of Medicine. It's called the plausible mechanism pathway, and it's basically combining gold standard science with common sense.”
Dr. Marty Makary Jan 15, 2026 ▶ 29:01 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Assertion Partly supported
FDA removes nine artificial petroleum-based food dyes from U.S. market
“Within weeks of coming into office, we took action to remove all nine artificial petroleum-based dyes.”
Dr. Marty Makary Jan 15, 2026 ▶ 5:21 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 negative
Disclosure
FDA changing regulations to close drug broadcast ad risk loophole
“We're closing that loop. We're changing the regulation to close that loop.”
Dr. Marty Makary Jan 15, 2026 ▶ 1:10:23 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Disclosure
Makary: FDA is customizing drug manufacturing requirements to specific patient populations
“The announcement that we made on Sunday was that we're going to customize the manufacturing requirements to the drug and the population being treated.”
Dr. Marty Makary Jan 15, 2026 ▶ 28:05 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 bullish
Disclosure
FDA hiring 1,050 new scientists to expand accelerated drug approval pathways
“We are actually hiring 1050 new scientists because we have very ambitious goals on our new pathways, accelerated type pathways, and so we're building up capacity to have a whole new line of pathways so that we can deliver faster for the American people.”
Dr. Marty Makary Jan 15, 2026 ▶ 7:31 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Disclosure
Makary: FDA deregulating health wearables unless claiming medical-grade accuracy
“They're going to be deregulated, so you can give those results of any physiologic parameter, but if you say that it's a quote unquote medical grade blood pressure, then we are going to want to see the data to make sure that it's validated with the gold standar…”
Dr. Marty Makary Jan 15, 2026 ▶ 1:13:25 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 neutral
Assertion Contradicted
Makary: No FDA scientific reviewers were laid off during administrative cuts
“No scientific reviewer was laid off, but there were significant consolidations in HR, procurement, IT, and the duplicative services that were out there.”
Dr. Marty Makary Jan 15, 2026 ▶ 6:28 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 negative
Assertion Partly supported
Makary: FDA sent zero drug ad enforcement letters in previous year
“The Biden folks in the year before I came to the FDA sent out zero enforcement letters. A department of about 35 people in charge of sending out enforcement letters sent out zero enforcement letters.”
Dr. Marty Makary Jan 15, 2026 ▶ 1:10:27 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Disclosure
FDA initiates regulatory process to close GRAS food chemical loophole
“And so we've said, we have to close the loophole on grass. We started the regulatory process to do that.”
Dr. Marty Makary Jan 15, 2026 ▶ 1:17:45 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Disclosure
FDA reduces biosimilar approval timeline from up to 8 years to 2.5
“We have changed the requirements so that we use the same principles we use for small molecules If you are structurally the same as a small molecule branded drug, we're going to approve you with some other stipulations. And so we are reducing the cost of R&D of…”
Dr. Marty Makary Jan 15, 2026 ▶ 1:01:57 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 positive
Prediction Open · timeframe Jan 2031
Makary: FDA will use AI to cut application reviews to one day
“It took, and you know, some often still takes, 60 days just for the FDA to tell you that your application is complete. We're going to get that down to one day. We're going to use AI.”
Dr. Marty Makary Jan 15, 2026 ▶ 11:12 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 15, 2026 negative
Assertion Supported
Makary: FDA halted Biden-era policy allowing CAR-T cell editing in China
“We did find that there was in the Biden administration approval to have the cells of Americans for CAR T therapy shipped to China where the Chinese did the gene editing and then shipped back to the United States. To infuse in Americans. When I found out about …”
Dr. Marty Makary Jan 15, 2026 ▶ 30:25 Supercharging a New FDA: Marty Makary on Science, Power & Patients
Feb 28, 2026 positive
Assertion Supported
Friedberg: Life Biosciences secured FDA agreement for first human Yamanaka factor trial
“He's a co-founder of a company called Life Biosciences, and they've reached a major agreement with the FDA to be the first company to treat humans with Yamanaka factors.”
David Friedberg Feb 28, 2026 ▶ 1:05:54 Software Stocks Implode, Claude's Hit List, State of the Union Reactions, Trump's Tariff Pivot
May 1, 2026 bullish
Prediction Not checkable as stated
Friedberg: FDA approval for Retatrutide could come as early as 2026
“That's what they're saying. Could happen sooner. I mean, the data's in, the, you know, the FDA will take their time to evaluate it, but I think given the way this is all looking, could happen sooner, could happen sometime later this year.”
David Friedberg May 1, 2026 ▶ 1:01:29 OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze
Jun 9, 2026 neutral
Insight
Maris: Finding a drug compound is only 5% of the work
“Because of the human biology and the FDA, if you find a compound, and you think you've got something, that's like five percent of the work.”
Bill Maris Jun 9, 2026 ▶ 22:22 Bill Maris: How Google Could Crush AI Competitors, Why Small Funds Win, and AI's Atari Stage
Jun 13, 2026 negative
Assertion Supported
Sacks: Anthropic CEO Dario Amodei advocated for FDA-style AI regulation
“Dario wrote a new blog post. Saying that transparency was no longer good enough, that we needed to have a new regulatory agency like an FAA or maybe an FDA to approve all models.”
David Sacks Jun 13, 2026 ▶ 16:11 Anthropic's Fable Backlash, Nationalizing AI, Inflation Heats Up & California’s Broken Elections
Aug 21, 2026 negative
Assertion Not checkable as stated
Friedberg: Slow FDA cycles are shifting global biotech investment to China
“And then separately, a lot of biotech has moved offshore from the U S for the same reason that you're pointing out, which is the FDA approval cycle. Is so long and the stages slow people down so much and China's completely revamped their rules for getting to c…”
David Friedberg Aug 21, 2026 ▶ 17:13 Dario Defends Himself, Datacenter Panic, AI Doomer Trap, Senate Toss-Up
Sep 4, 2026 negative
Prediction Not checkable as stated
Sacks: An FDA-style AI regulatory agency will not happen under Trump
“Setting up a new AI Regulatory agency that operates like the FDA and takes years to approve new models. But in any event, I don't think that's gonna happen under President Trump.”
David Sacks Sep 4, 2026 ▶ 5:30 GPT-6 Hits AGI? Tech Euphoria 2.0, SF Mansion Shortage, NYC Bans AI in Schools & Venezuela Oil Deal
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 460 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.